Quaker Chemical (KWR) director exercises options, covers tax with shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Quaker Chemical director Michael F. Barry reported stock option and related share transactions. On February 10, 2026, he exercised 8,212 employee stock options at an exercise price of $136.64 per share, receiving the same number of common shares.
On the same date, 6,876 common shares were disposed of at $176.06 per share to cover the exercise price or tax obligations, a non‑open‑market transaction coded "F." After these transactions, Barry directly owned 78,010 shares of Quaker Chemical common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
8,212 shares exercised/converted
Mixed
3 txns
Insider
BARRY MICHAEL F
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 8,212 | $0.00 | -- |
| Exercise | Common Stock | 8,212 | $136.64 | $1.12M |
| Tax Withholding | Common Stock | 6,876 | $176.06 | $1.21M |
Holdings After Transaction:
Employee Stock Option (right to buy) — 0 shares (Direct);
Common Stock — 84,886 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transactions did KWR director Michael F. Barry report?
Michael F. Barry reported exercising 8,212 Quaker Chemical (KWR) stock options and receiving the same number of common shares. He also had 6,876 shares withheld in a coded "F" transaction to cover the exercise price or tax obligations, leaving 78,010 shares owned directly.
What do the Form 4 transaction codes M and F mean for KWR?
For Quaker Chemical (KWR), code "M" shows Michael F. Barry exercised 8,212 employee stock options at $136.64, converting them into common shares. Code "F" indicates 6,876 shares were delivered to cover the exercise price or tax liability, rather than sold in the open market.
What vesting schedule applied to Michael F. Barry’s KWR stock options?
The reported Quaker Chemical (KWR) stock option grant vested annually in three tranches: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023. The 2026 transaction reflects the exercise of the final vested portion.